Cannabinoid-based solutions for agriculture, livestock, food preservation, skincare, and pet care

Publication ID: 24-11857530_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Cannabinoid-based solutions for agriculture, livestock, food preservation, skincare, and pet care,” Published Technical Disclosure No. 24-11857530_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857530_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,530.

Summary of the Inventive Concept

The inventive concept applies the core technology of cannabinoid formulations to novel industries, providing tailored solutions for optimizing agricultural crop yields, reducing stress in livestock, enhancing the shelf life of perishable foods, improving the efficacy of skincare products, and reducing anxiety in pets.

Background and Problem Solved

The original patent disclosed cannabinoid formulations aligned with an individual's genotype. However, the potential of cannabinoids extends beyond human health to various industries. The inventive concept addresses the limitations of the original patent by exploring new applications and use cases, leveraging the unique properties of cannabinoids and terpenes to solve specific problems in agriculture, livestock, food preservation, skincare, and pet care.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of novel applications, including: (1) a system for optimizing agricultural crop yields by tailoring cannabinoid formulations to specific plant genotypes; (2) a method for reducing stress in livestock through targeted cannabinoid formulations; (3) a composition for enhancing the shelf life of perishable foods by leveraging the antimicrobial properties of cannabinoids; (4) a system for improving the efficacy of skincare products by utilizing topical cannabinoid formulations with specific terpene profiles; and (5) a method for reducing anxiety in pets through targeted cannabinoid formulations. Each application leverages the unique properties of cannabinoids and terpenes to provide innovative solutions.

Novelty and Inventive Step

The inventive concept's novelty lies in its application of cannabinoid formulations to entirely new industries, addressing specific problems and needs. The inventive step resides in the tailored design of cannabinoid formulations to solve these problems, demonstrating a non-obvious extension of the original patent's technology.

Alternative Embodiments and Variations

Alternative embodiments may include varying the cannabinoid-to-terpene ratio, using different terpene profiles, or incorporating additional compounds to enhance the efficacy of the formulations. Variations may also involve adapting the formulations for use in other industries, such as textiles or construction materials.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential, with applications in agriculture, livestock, food preservation, skincare, and pet care. The market for these solutions is substantial, with opportunities for partnerships, licensing, and product development.

Field of Art

Pharmaceutical and biotechnology formulations, specifically cannabinoid composition design and application across multiple domains including agriculture, veterinary medicine, food science, and personal care

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, biotechnology, or related fields, possessing expertise in formulation chemistry, cannabinoid pharmacology, and interdisciplinary product development

Obviousness Rationale

A PHOSITA would recognize that the source patent's cannabinoid formulation principles inherently suggest broad applicability across multiple technical domains. The fundamental understanding of cannabinoid interactions with biological systems provides a predictable framework for extending the technology into novel application areas. The PTD demonstrates systematic adaptation of known cannabinoid composition techniques to solve specific industry challenges, which represents an incremental and obvious technological progression.

Obvious Combinations & Variations

Source Patent Element
Cannabinoid formulation with specific CBD:THC ratios and terpene profiles
PTD Variation
Applying cannabinoid formulations to agricultural crop enhancement and stress reduction
Obviousness Reasoning
A PHOSITA would recognize that cannabinoids' known biological interactions could be predictably extended to plant and animal systems as a known technique for modulating physiological responses
Source Patent Element
Formulation comprising multiple cannabinoids and terpenes
PTD Variation
Utilizing cannabinoid compositions for food preservation and antimicrobial applications
Obviousness Reasoning
The inherent antimicrobial properties of cannabinoids are well-understood, making their application to food preservation a predictable and obvious design choice for someone skilled in the art
Source Patent Element
Cannabinoid formulation with specific terpene concentrations
PTD Variation
Developing topical skincare formulations with targeted terpene profiles
Obviousness Reasoning
Transdermal delivery and skin interaction of cannabinoids represent a known technique, with terpene modulation being a standard approach for enhancing absorption and efficacy
Source Patent Element
Cannabinoid composition with variable compound concentrations
PTD Variation
Creating anxiety-reduction formulations for pets using specific cannabinoid and terpene ratios
Obviousness Reasoning
The known anxiolytic properties of cannabinoids, combined with established veterinary pharmaceutical techniques, would suggest an obvious approach to developing animal-specific formulations
Source Patent Element
Genotype-based cannabinoid formulation approach
PTD Variation
Tailoring cannabinoid compositions to specific biological systems across different domains
Obviousness Reasoning
The source patent's foundational approach of designing formulations based on biological characteristics provides a clear template for systematic adaptation across multiple technical fields
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857530, the present published technical disclosure demonstrates that the claimed variations in cannabinoid formulation and application represent obvious extensions of prior art, wherein a person having ordinary skill in the art would readily recognize the predictable combination of known cannabinoid composition techniques with specific industry challenges, thus rendering such variations non-patentable under standard obviousness criteria.

Original Patent Information

Patent NumberUS 11,857,530
TitleCannabinoid formulations
Assignee(s)Endocanna Health, Inc.